Rani Therapeutics Holdings, Inc. SEC filings RANI
Rani Therapeutics Holdings, Inc. has 380 filings in SEC EDGAR's recent list, going back to Apr 27, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| D | Filing | Nov 10, 2025 | — |
| EFFECT | Filing | Aug 14, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2025 | — |
| EFFECT | Filing | Jul 11, 2025 | — |
| CORRESP | Letter to the SEC | Jul 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2025 | — |
| EFFECT | Filing | Dec 29, 2022 | — |
| CORRESP | Letter to the SEC | Dec 27, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2022 | — |
| EFFECT | Filing | Aug 10, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| CORRESP | Letter to the SEC | Aug 9, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2022 | — |
| NT 10-Q | Filing | Nov 16, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Jul 29, 2021 | — |
| CERT | Filing | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| 8-A12B | Filing | Jul 26, 2021 | — |
| CORRESP | Letter to the SEC | Jul 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| DRSLTR | Filing | Jun 22, 2021 | — |
| DRS/A | Filing | Jun 22, 2021 | — |
| UPLOAD | Letter from the SEC | May 26, 2021 | — |
| DRS | Filing | Apr 27, 2021 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RANI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- San Jose, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1856725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.